Novo Nordisk (NVO) hits record highs as study shows Wegovy treatment cut the risk of heart issues by 20%
Go back to Novo Nordisk (NVO) hits record highs as study shows Wegovy treatment cut the risk of heart issues by 20%| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1102.08 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1102.08 | 52 Week High | $88.16 | |||
| Open | $1102.08 | 52 Week Low | $67.88 | |||
| Day High | $1102.08 | P/E | 255.11 | |||
| Day Low | $1102.08 | EPS | $4.32 | |||
| Volume | 8,407 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 45.88 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.88 | 52 Week High | $59.00 | |||
| Open | $45.88 | 52 Week Low | $32.80 | |||
| Day High | $45.88 | P/E | N/A | |||
| Day Low | $45.88 | EPS | $0.00 | |||
| Volume | 380,410 | |||||
